Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or delivering the wrong diagnosis.
Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...
NEW YORK – Hepion Pharmaceuticals has acquired the rights to develop Cirna Diagnostics' circulating tumor RNA (ctRNA) biomarker assay that can detect early, high-risk hepatocellular carcinoma, the ...
Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancerLicensing deal reflects ...
Opinion
2dOpinion
Why RFK’s hepatitis B vaccine policy puts a generation of children at risk in US and beyond
The Trump administration has been notable for the polarising views it elicits. As an obstetrician who has delivered thousands of babies, I believe I am on very strong ground in asserting that what ...
Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...
Liver enzymes help break down food and turn it into energy and nutritional elements, among other things. Elevated levels ...
Joint AASLD/IDSA practice recommendations reflect new data on prevention, treatment, and surveillance of chronic hepatitis B, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results